Coenzyme Q10 and Folic Acid: study protocols
8 study groups took Coenzyme Q10 together with Folic Acid. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Coenzyme Q10
8 study groups in 8 studies say how much Coenzyme Q10 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 50% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg to 2.5 mg | 4 |
| 2.5 mg to 5 mg | 0 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 0 |
| 25 mg to 50 mg | 2 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 1 |
Dose per serving from research: Folic Acid
8 study groups in 8 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mcg to 250 mcg, 63% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 5 |
| 250 mcg to 500 mcg | 2 |
| 500 mcg to 1 mg | 1 |
Commonly used together
8 of 8 study groups took Coenzyme Q10 and Folic Acid with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Red Yeast Rice | 5 |
| Berberine | 4 |
| Policosanol | 4 |
| Astaxanthin | 3 |
| Vitamin B12 | 3 |
8 study groups
| Study | ||||
|---|---|---|---|---|
| Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial 2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment | 150 mg | 400 mcg | 90 days | 63 |
| Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial 2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant | 2 mg | 200 mcg | 4 weeks | 23 |
| Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study 2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia | 2 mg | 200 mcg | 4 weeks | — |
| Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial 2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment | 2 mg | 200 mcg | 12 weeks | 51 |
| Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial 2017 · Active nutraceutical · Adults aged 25–75 with moderately elevated cholesterol and metabolic syndrome, in primary cardiovascular prevention | 50 mg | 110 mcg | 6 weeks | 30 |
| The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial 2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS) | 30 mg | 800 mcg | 90 days | 30 |
| Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function 2018 · verum group · Adults aged 18–75 with cardiac arrhythmias (ventricular or supraventricular premature beats or supraventricular tachycardia); patients with cardiovascular disorders, often including hypertension or coronary artery disease | 60 mg | 400 mcg | 6 weeks | 29 |
| Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial 2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded. | 2 mg | 200 mcg | 6 weeks | 23 |